Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAsa Int Regulatory News (ASAI)

Share Price Information for Asa Int (ASAI)

Share Price is delayed by 15 minutes
Get Live Data
200.00    0.00 (0.00%)
Bid:
198.50
Ask:
200.00
Spread: 1.50 (0.756%)
Market Cap: £195.62m
ASAI Live PriceLast checked at - London Stock Exchange

Intraday Asa Int Share Chart

COVID-19 Potential Impact Statement

30 Mar 2020 07:00

RNS Number : 9574H
ASA International Group PLC
30 March 2020
 

 

COVID-19 Potential Impact Statement

 

Amsterdam, 30 March 2020 - ASA International Group plc, ("ASA International", the "Company" or the "Group"), one of the world's largest international microfinance institutions, today announces the potential impact of the spread of COVID-19 on its clients, employees and operations.

In recent weeks the number of known infections of COVID-19 started to rapidly increase in many of our operating countries, which caused governments in these countries to take stringent measures to halt the further spread of COVID-19, including, amongst others, lockdowns, curfews, self-isolation, mandatory quarantine, the closure of public places (markets), restrictions on public gatherings and travel.

Some of these measures, in particular the imposition of a temporary lockdown, are expected to materially impact the income generating capacity of our clients and reduce the ability of our staff to conduct regular client meetings and collect loan instalments.

In mitigating the impact of COVID-19, we will be focusing on our clients and delivering operational efficiency and cost savings across our business:

· Clients: strengthening client interaction by (smart) phone or other digital devices, collecting through group leader where possible, increasing digital collections (m-pesa, bank transfer or other payment platform), switching from weekly to bi-weekly or monthly collection where appropriate, while maintaining CSR programmes where possible in support of our clients

· Cost savings: adjusting field capacity during lockdowns, pay freezes, postponement of non-priority projects and deferral of non-essential operating expenses

Operating performance was in-line with our expectations during the first two months of 2020 without any discernible impact of COVID-19 on our loan portfolio. However, given the recent measures that governments have put or are planning to put in place to prevent the spread of COVID-19 in an increasing number of our operating countries, we expect that our business will be adversely impacted. While it is too early to quantify, we expect it will materially impact our financial performance and as a result, we withdraw our previous guidance for 2020.

As of 30 March 2020, the Company has a strong balance sheet, including approximately USD 75m of unrestricted cash across the group, and at group holding level in excess of USD 15m of undrawn credit facilities and no major debt re-financings until 2021. We decided to suspend the 2019 dividend until a final decision later in the year. The Group is in ongoing discussions about the recent developments with regulators and lenders who recognise the strength of the Group's balance sheet and business model.

Subject to regulatory developments in the UK about financial reporting and COVID-19, the Group plans to announce its 2019 annual results on 21 April 2020.

Enquiries:

ASA International Group plc

Investor Relations +31 6 2030 0139

Véronique Schyns vschyns@asa-international.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDFLFIAVLIAFII
Date   Source Headline
3rd Jun 20262:14 pmRNSResult of 2026 Annual General Meeting
21st May 20267:00 amRNSDirector/PDMR Shareholding
6th May 20262:56 pmRNSDirector/PDMR Shareholding
5th May 20267:00 amRNSAppointment of Chairman and Board Update
30th Apr 20267:00 amRNSNotice of Annual General Meeting
30th Apr 20267:00 amRNSQ1 2026 Business Update
28th Apr 20267:00 amRNSAppointment of Independent Non-Executive Director
15th Apr 20267:00 amRNSFY 2025 Results
24th Feb 20267:00 amRNSDirector/PDMR Shareholding
6th Feb 20267:00 amRNSDirector/PDMR Shareholding
30th Jan 20261:31 pmRNSDirector/PDMR Shareholding
29th Jan 20267:00 amRNSQ4 2025 Trading and Business Update
13th Jan 20263:31 pmRNSHolding(s) in Company
9th Jan 20261:50 pmRNSDirector/PDMR Shareholding
9th Jan 20261:49 pmRNSDirector/PDMR Shareholding
19th Dec 202511:15 amRNS2025 Annual General Meeting Update Statement
19th Dec 202511:15 amRNS2025 Annual General Meeting Update Statement
17th Dec 20253:35 pmRNSAppointment of Non-Executive Director
4th Dec 20257:00 amRNSTrading Update
28th Nov 20259:36 amRNSHolding(s) in Company
10th Nov 20257:57 amRNSDirector/PDMR Shareholding
7th Nov 20259:38 amRNSHolding(s) in Company
6th Nov 20257:00 amRNSCFO Appointment
5th Nov 20255:31 pmRNSHolding(s) in Company
5th Nov 20255:27 pmRNSDirector/PDMR Shareholding
28th Oct 20252:20 pmRNSGrant of Options
27th Oct 20254:44 pmRNSDirector/PDMR Shareholding
21st Oct 20257:00 amRNSQ3 2025 Business Update
10th Oct 20253:29 pmRNSHolding(s) in Company
10th Oct 20253:28 pmRNSHolding(s) in Company
8th Oct 202512:44 pmRNSHolding(s) in Company
24th Sep 20257:00 amRNS2025 Interim Results
11th Aug 202512:20 pmRNSDirector/PDMR Shareholding
30th Jul 20254:32 pmRNSHolding(s) in Company
29th Jul 202511:12 amRNSHolding(s) in Company
23rd Jul 20259:40 amRNSDirector/PDMR Shareholding
22nd Jul 20257:00 amRNSQ2 2025 Business Update
19th Jun 20252:13 pmRNSResult of AGM
6th Jun 20257:00 amRNSDirectorate Change
20th May 20257:00 amRNSNotice of Annual General Meeting
24th Apr 20257:00 amRNS2024 Results
24th Apr 20257:00 amRNSAppointment of Independent Non-Executive Director
24th Apr 20257:00 amRNSQ1 2025 Business Update
20th Mar 20257:00 amRNSBoard and Leadership Update
10th Mar 202511:18 amRNSHolding(s) in Company
5th Mar 20254:27 pmRNSNotification of Major Holdings
5th Mar 20254:23 pmRNSNotification of Major Holdings
21st Jan 20257:00 amRNSQ4 2024 Trading and Business Update
8th Jan 20252:46 pmRNSDirector Remuneration Update
7th Jan 202512:14 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.